What is the role of inhaled antibiotic therapy for nosocomial pneumonia?

Updated: Apr 15, 2021
  • Author: Kartika Shetty, MD, FACP; Chief Editor: John L Brusch, MD, FACP  more...
  • Print
Answer

Answer

The use of inhaled antibiotic therapy should be generally limited to cases of VAP produced by gram-negative bacilli that are sensitive only to aminoglycosides or polymyxins (colistin or polymyxin B). These antibiotics should also be administered systemically. [32]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!